Ethical issues in medical cannabis use

      Highlights

      • The increasing use of medical cannabis (MC) in the previous decade has raised several ethical issues.
      • Although most of these concerns are common to prescribing any medical regimen, some are unique to MC utilization.
      • In the current review we will discuss these issues in the light of the current experience of MC continuously expended use.

      Abstract

      The increasing use of medical cannabis (MC) in the past decade raises several ethical considerations for the clinician. Regulatory issues stem from a gap between MC registration and certification in each country. Professional issues derive from the lack of sufficient knowledge of MC characteristics and the intersection between the physician, the patient and commercial interests. Finally, there are medical and psychological implications which are related to the use of MC regimens. We will discuss these issues in the light of the current era, in which policy has rapidly shifted toward legalization of cannabis, which influences the decisions of both clinicians and patients.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Elliott A.M.
        • Smith B.H.
        • Penny K.I.
        • Smith W.C.
        • Chambers W.A.
        The epidemiology of chronic pain in the community.
        Lancet. 1999; 354: 1248-1252
        • Torrance N.
        • Smith B.H.
        • Bennett M.I.
        • Lee A.J.
        The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey.
        J Pain. 2006; 7: 281-289
        • ABC News, USA Today, Stanford Medical Center Poll
        Broad experience with pain sparks search for relief [online].
        (Available at)
        • Ogborne A.C.
        • Smart R.G.
        • Adlaf E.M.
        Self-reported medical use of marijuana: a survey of the general population.
        CMAJ. 2000 Jun 13; 162: 1685-1686
      1. Marinol (Dronabinol).
        (Available at:)
        • Perez J.
        • Ribera M.V.
        Managing neuropathic pain with Sativex®: a review of its pros and cons.
        Expert Opin Pharmacother. 2008; 9: 1189-1195
        • Ashton C.H.
        Pharmacology and effects of cannabis: a brief review.
        Br J Psychiatry. 2001 Feb; 178: 101-106
        • Russo E.B.
        11 the solution to the medicinal cannabis problem.
        in: Ethical issues chron. pain manage. 165. 2006
        • The Official Website of the Executive Office of Health and Human Services
        Guidance for physicains on the medical use of marijuana.
        (Available at)
        • U.S Department of Justice
        Title 21 United States code (USC) controlled substances act.
        (Available at)
        • Kondrad E.
        • Reid A.
        Colorado family physicians' attitudes toward medical marijuana.
        J Am Board Fam Med. 2013 Jan-Feb; 26: 52-60
        • Calabria B.
        • Degenhardt L.
        • Hall W.
        • Lynskey M.
        Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use.
        Drug Alcohol Rev. 2010; 29: 318-330
        • Lev-Ran S.
        • Roerecke M.
        • Le Foll B.
        • George T.
        • McKenzie K.
        • Rehm J.
        The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies.
        Psychol Med. 2014; 44: 797-810
        • Sally Bean J.D.M.
        Medical cannabis: identifying ethical and policy implications for healthcare organizations in Canada.
        J Pain Manag. 2016; 9: 473
        • Leung L.
        Cannabis and its derivatives: review of medical use.
        J Am Board Fam Med. 2011 Jul-Aug; 24: 452-462
        • Herrmann E.S.
        • Cone E.J.
        • Mitchell J.M.
        • Bigelow G.E.
        • LoDico C.
        • Flegel R.
        • et al.
        Non-smoker exposure to secondhand cannabis smoke II: effect of room ventilation on the physiological, subjective, and behavioral/cognitive effects.
        Drug Alcohol Depend. 2015; 151: 194-202
        • Fried P.A.
        • Watkinson B.
        36-and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol.
        J Dev Behav Pediatr. 1990; 11: 49-58
        • Wang G.S.
        • Roosevelt G.
        • Heard K.
        Pediatric marijuana exposures in a medical marijuana state.
        JAMA Pediatr. 2013; 167: 630-633
        • Rosenblatt R.A.
        • Catlin M.
        Opioids for chronic pain: first do no harm.
        Ann Fam Med. 2012 Jul-Aug; 10: 300-301
        • Sullivan M.D.
        • Edlund M.J.
        • Fan M.
        • DeVries A.
        • Braden J.B.
        • Martin B.C.
        Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study.
        Pain. 2010; 150: 332-339
        • Johnston L.D.
        • O'Malley P.M.
        • Bachman J.G.
        • Schulenberg J.E.
        Monitoring the future national results on adolescent drug use: overview of key findings.
        Institute for Social Research, 2011: 2012
        • Schuermeyer J.
        • Salomonsen-Sautel S.
        • Price R.K.
        • Balan S.
        • Thurstone C.
        • Min S.
        • et al.
        Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003–11.
        Drug Alcohol Depend. 2014; 140: 145-155
        • Thurstone C.
        • Lieberman S.A.
        • Schmiege S.J.
        Medical marijuana diversion and associated problems in adolescent substance treatment.
        Drug Alcohol Depend. 2011; 118: 489-492
        • Volkow N.D.
        • Baler R.D.
        • Compton W.M.
        • Weiss S.R.
        Adverse health effects of marijuana use.
        N Engl J Med. 2014; 370: 2219-2227
        • Hall W.
        • Degenhardt L.
        Adverse health effects of non-medical cannabis use.
        Lancet. 2009; 374: 1383-1391
        • Gorelick D.A.
        • Levin K.H.
        • Copersino M.L.
        • Heishman S.J.
        • Liu F.
        • Boggs D.L.
        • et al.
        Diagnostic criteria for cannabis withdrawal syndrome.
        Drug Alcohol Depend. 2012; 123: 141-147
        • Chen C.
        • Storr C.L.
        • Anthony J.C.
        Early-onset drug use and risk for drug dependence problems.
        Addict Behav. 2009; 34: 319-322
        • Zalesky A.
        • Solowij N.
        • Yücel M.
        • Lubman D.I.
        • Takagi M.
        • Harding I.H.
        • et al.
        Effect of long-term cannabis use on axonal fibre connectivity.
        Brain. 2012; 135: 2245-2255
        • Meier M.H.
        • Caspi A.
        • Ambler A.
        • Harrington H.
        • Houts R.
        • Keefe R.S.
        • et al.
        Persistent cannabis users show neuropsychological decline from childhood to midlife.
        Proc Natl Acad Sci U S A. 2012 Oct 2; 109: E2657-64
        • DiNieri J.A.
        • Wang X.
        • Szutorisz H.
        • Spano S.M.
        • Kaur J.
        • Casaccia P.
        • et al.
        Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring.
        Biol Psychiatry. 2011; 70: 763-769
        • Agrawal A.
        • Neale M.C.
        • Prescott C.A.
        • Kendler K.S.
        A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs.
        Psychol Med. 2004; 34: 1227-1237
        • Khantzian E.J.
        The self-medication hypothesis of substance use disorders: a reconsideration and recent applications.
        Harv Rev Psychiatry. 1997; 4: 231-244
        • Patton G.C.
        • Coffey C.
        • Carlin J.B.
        • Degenhardt L.
        • Lynskey M.
        • Hall W.
        Cannabis use and mental health in young people: cohort study.
        BMJ. 2002 Nov 23; 325: 1195-1198
        • Caspi A.
        • Moffitt T.E.
        • Cannon M.
        • McClay J.
        • Murray R.
        • Harrington H.
        • et al.
        Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
        Biol Psychiatry. 2005; 57: 1117-1127
        • Lynskey M.
        • Hall W.
        The effects of adolescent cannabis use on educational attainment: a review.
        Addiction. 2000; 95: 1621-1630
        • Degenhardt L.
        • Hall W.
        Extent of illicit drug use and dependence, and their contribution to the global burden of disease.
        Lancet. 2012; 379: 55-70